Product Catalog/Weight Management/Retatrutide
Weight Management

Retatrutide

GLP-1 / GIP / Glucagon Triple Agonist

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, studied for its potent effects on body weight reduction and metabolic health in research models.

Purity
≥99.0%
Form
Lyophilized Powder
Molecular Weight
4859.5 Da
Amino Acid Sequence

Tyr-Aib-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Gly-Lys-Gly-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

Pricing & Availability
Available to approved wholesale partners only.
Apply for Access
Certificate of Analysis
Retatrutide
APPROVED
Test Results — Batch #5MQ68C
Identity (HPLC/MS)
Confirmed by MSPASS
Purity (HPLC)
99.0%PASS
Endotoxin (LAL)
< 0.1 EU/mgPASS
Moisture Content
2.2%PASS
Appearance
White Lyophilized PowderPASS
Sterility
No Growth DetectedPASS
Third-Party Verified
Full COA available to partners
Research Applications
  • Triple incretin receptor research
  • Obesity and metabolic disease models
  • Hepatic fat reduction studies
  • Energy expenditure research